chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 63.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Cerebrovascular accident, SARS-CoV-2 test
Clinical narrative: Nasal Swab Positive; Nasal Swab Positive; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 64-year-old male patient received BNT162b2 (BNT162B2), on 09Mar2021 at 12:00 as dose 1, single (Lot number: EN6200, Expiration Date: 30Jun2021), in left arm and on 30Mar2021 at 16:00 as dose 2, single (Lot number: ER8733, Expiration Date: 31Jul2021) at the age of 63 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "High BP" (unspecified if ongoing); "cholesterol" (unspecified if ongoing); "neuropathy" (unspecified if ongoing). The patient took concomitant medications. Past drug history included: Sulfa, reaction(s): "allergy". The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset Jan2022, outcome "recovered" and all described as "Nasal Swab Positive". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (Jan2022) Positive; (Jan2023) Negative. Other medications in two weeks: Yes. Patient had no covid prior vaccination.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202300143276 same vaccine/patient, different dose/event;US-PFIZER INC-202300143181 same vaccine/patient, different dose/event;
Age: 63.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: COVID-19, SARS-CoV-2 test, Vaccination failure
Clinical narrative: Nasal Swab Positive; Nasal Swab Positive; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 64-year-old male patient received BNT162b2 (BNT162B2), on 09Mar2021 at 12:00 as dose 1, single (Lot number: EN6200, Expiration Date: 30Jun2021), in left arm and on 30Mar2021 at 16:00 as dose 2, single (Lot number: ER8733, Expiration Date: 31Jul2021) at the age of 63 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "High BP" (unspecified if ongoing); "cholesterol" (unspecified if ongoing); "neuropathy" (unspecified if ongoing). The patient took concomitant medications. Past drug history included: Sulfa, reaction(s): "allergy". The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset Jan2022, outcome "recovered" and all described as "Nasal Swab Positive". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (Jan2022) Positive; (Jan2023) Negative. Other medications in two weeks: Yes. Patient had no covid prior vaccination.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202300143276 same vaccine/patient, different dose/event;US-PFIZER INC-202300143181 same vaccine/patient, different dose/event;
Sex: U
Vaccine: HPV9
Symptoms: No adverse event
Clinical narrative: No adverse events; Pharmacist reporting an AE. Caller stated a patient received the first dose of GARDASIL 9 in 2020 and then received the second dose 5 months ago (in 2022). No additional AE reported. No PQC.  2020, then 5 months ago start over if time is ; This spontaneous report was received from a pharmacist and refers to a patient of unknown age and gender. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported.  On an unknown date in 2020, the patient received the first dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) administered for prophylaxis (strength, lot #, expiry date, and route of administration were not provided).  In approximately October 2022 (reported as "5 months ago"), the patient received the second dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9). No adverse events were reported.
Age: 1.08
Sex: M
Vaccine: HEPA
Symptoms: Expired product administered, No adverse event
Clinical narrative: No adverse event; Nurse reported that an expired VAQTA was given to a patient today.  No additional AEs were reported, No further information provided.  No PQC.; This spontaneous report was received from a registered nurse, and refers to a 13-month-old male patient. The patient's medical history was not reported. The patient's concurrent conditions, concomitant therapies and medical history were not reported.  On 08-MAR-2023, the patient was vaccinated with an expired dose of hepatitis a vaccine, inactivated (VAQTA) prefilled syringe, intramuscularly, in the right tight, 0.5 milliliters once, lot #W006214, for prophylaxis.  The administered dose of hepatitis a vaccine, inactivated (VAQTA) expired on 04-MAR-2023. The vaccine was obtained with private funds.   The physician was informed. No adverse events were reported.
Sex: U
Vaccine: MMRV
Symptoms: No adverse event, Product storage error
Clinical narrative: No additional AE reported; Improperly Stored / Administered Vaccine; This spontaneous report was received from a nurse and refers to a patient of unknown age and gender.  The patient's medical history and concurrent conditions were not reported. The concomitant medication included sterile diluent (lot# T029529, expiration date: 16-APR-2023).   On 03-APR-2023 (at around 10 AM), the patient was vaccinated with improperly stored dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live rHA (PROQUAD) lot #W036929, expiration date: 19-MAY-2024 (exact dose, route of administration and anatomical location were not reported) for prophylaxis (product storage error).  On 02-APR-2023, vaccine was exposed to temperature excursion of 26.6 degrees Fahrenheit for 2 hours and 8 minutes. It was reported that the previous temperature excursion took placed on 01-APR-2023, of 14 degrees Fahrenheit to 46 degrees Fahrenheit (18.1 degrees Fahrenheit) for 1 hour and 20 minutes. No additional adverse event reported (no adverse event).
Sex: M
Vaccine: VARZOS
Symptoms: Feeling abnormal, Herpes zoster, Vaccination failure
Clinical narrative: shingles after 9 months of Shingrix/suspected vaccination failure; shingles in brain; felt like hit me with pick ax; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a male patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, 9 months after receiving Shingrix, the patient experienced vaccination failure (Verbatim: shingles after 9 months of Shingrix/suspected vaccination failure) (serious criteria GSK medically significant), shingles (Verbatim: shingles in brain) and feeling abnormal (Verbatim: felt like hit me with pick ax). The outcome of the vaccination failure and shingles were unknown and the outcome of the feeling abnormal was not reported.   The reporter considered the vaccination failure, shingles and feeling abnormal to be related to Shingrix.     The company considered the vaccination failure, shingles and feeling abnormal to be related to Shingrix.   Additional Information: GSK receipt date: 31-Mar-2023 The case was received from the patient via interactive digital media. The patient got the Shingrix vaccine and nine months later got shingles, it settled in his left side brain felt like someone came up and hit him with pick ax right above ear horrible Shingrix was 90 percent well and got the 10 bs. The reporter denied to follow-up. This case was considered as suspected vaccination failure since the details regarding the completion of primary vaccination schedule, time to onset and laboratory confirmation of shingles were unknown at the time of reporting.
Sex: F
Vaccine: VARZOS
Symptoms: Herpes zoster, Vaccination failure
Clinical narrative: took the shot and still had them (shingles)/suspected vaccination failure; still had them; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a female patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   The patient's past medical history included shingles.   On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced vaccination failure (Verbatim: took the shot and still had them (shingles)/suspected vaccination failure) (serious criteria GSK medically significant) and shingles (Verbatim: still had them ). The outcome of the vaccination failure was unknown and the outcome of the shingles was not reported.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.     It was unknown if the company considered the vaccination failure and shingles to be related to Shingles vaccine.   Additional Information: GSK receipt date: 31-Mar-2023 The case was received from the patient via interactive digital media. The patient stated that you can say what you want about shingles but she took the shot and still had them.  This made her second time to had them so as far as the patient was concerned their was absolutely nothing you can do to prevent shingles. The patient's friend was diagnosed with shingles and could not believe how painful it was.  The patient was at a chapter in her life where she should be enjoying it to the fullest and she did not want to be on the sidelines because of shingles. Prevention was possible, learn more about the risk of shingles for people 50 plus. This case was considered as suspected vaccination failure since the details regarding the completion of primary vaccination schedule, time to onset and laboratory confirmation of shingles were unknown at the time of reporting. The follow-up could not be possible as no contact details were available.
Sex: U
Vaccine: VARZOS
Symptoms: Asthenia, Atrial fibrillation, Herpes zoster, Pain, Vaccination failure
Clinical narrative: Had the shot and shingles / Suspected vaccination failure; AFib; Shingles; Takes all energy, drained; Had worse pain, extremely painful, still have pain; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingrix) for prophylaxis.  On an unknown date, the patient received Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced vaccination failure (Verbatim: Had the shot and shingles/ Suspected vaccination failure) (serious criteria GSK medically significant), atrial fibrillation (Verbatim: AFib) (serious criteria GSK medically significant), shingles (Verbatim: Shingles), energy decreased (Verbatim: Takes all energy, drained) and pain (Verbatim: Had worse pain, extremely painful, still have pain). The outcome of the vaccination failure was unknown and the outcome of the atrial fibrillation, shingles and energy decreased were not reported and the outcome of the pain was not resolved.  It was unknown if the reporter considered the vaccination failure, atrial fibrillation, shingles, energy decreased and pain to be related to Shingrix.  It was unknown if the company considered the vaccination failure, atrial fibrillation, shingles, energy decreased and pain to be related to Shingrix.  Additional Information: GSK Receipt Date: 01-APR-2023 This case was reported by the patient via interactive digital media.  The reporter stated that he/she had the worse pain and had Atrial fibrillation (AFib) and shingles the same time. The pain was extremely painful and takes all your energy drained. The pain had lasted for more than two months, still had some pain and he/she had the shot but guess it was wearing out. The reporter prays that you did not get it. What was shingles worse than, for him/her, it was worse than getting a root canal.  The pain was so intense. This Shingles awareness week, tell him/her what else shingles was worse than. Let someone over 50 know, so they could be informed about how painful shingles. This case was considered as suspected vaccination failure as details regarding completion of primary schedule, time to onset and laboratory test confirming shingles were unknown at the time of reporting. Follow-up would not possible as no contact details were available.
Sex: U
Vaccine: VARZOS
Symptoms: Herpes zoster, Vaccination failure
Clinical narrative: Had the shot and had a reaction/Suspected vaccination failure; Shingles; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced vaccination failure (Verbatim: Had the shot and had a reaction/Suspected vaccination failure) (serious criteria GSK medically significant) and shingles (Verbatim: Shingles). The outcome of the vaccination failure was unknown and the outcome of the shingles was not reported.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.   It was unknown if the company considered the vaccination failure and shingles to be related to Shingles vaccine.   Additional Information: GSK Receipt Date: 15-MAR-2023 This case was reported by a patient via  interactive digital media. The patient had the shingles shot and had a reaction (shingles). This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset and laboratory test confirming shingles were unknown at the time of reporting. The follow up would not possible as no contact details were available.
Sex: U
Vaccine: VARZOS
Symptoms: Herpes zoster, Vaccination failure
Clinical narrative: Got the shot and got shingles/ suspected vaccination failure; Shingles; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced vaccination failure (Verbatim: Got the shot and got shingles/ suspected vaccination failure) (serious criteria GSK medically significant) and shingles (Verbatim: Shingles). The outcome of the vaccination failure was unknown and the outcome of the shingles was not reported.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.     It was unknown if the company considered the vaccination failure and shingles to be related to Shingles vaccine.   Additional Information: GSK Receipt Date: 15-MAR-2023 This case was reported by a patient via  interactive digital media. The patient reported that he or she received shingles vaccine and still experienced shingles which are terrible. This case was considered as suspected vaccination failure as details regarding completion of primary schedule, time to onset for shingles and laboratory confirmation regarding shingles were unknown at the time of reporting. Follow-up would not possible as no contact details were available.
Sex: U
Vaccine: VARZOS, VARZOS
Symptoms: Herpes zoster, Vaccination failure
Clinical narrative: Got the 2 shots and still got shingles/ suspected vaccination failure; Shingles; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingles vaccine and the 1st dose of Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine and Shingles vaccine, the patient experienced vaccination failure (Verbatim: Got the 2 shots and still got shingles/ suspected vaccination failure) (serious criteria GSK medically significant) and shingles (Verbatim: Shingles). The outcome of the vaccination failure was unknown and the outcome of the shingles was not reported.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine and Shingles vaccine.     It was unknown if the company considered the vaccination failure and shingles to be related to Shingles vaccine and Shingles vaccine.   Additional Information: GSK Receipt Date: 15-MAR-2023 This case was reported by a patient via  interactive digital media. The patient reported that he or she received two doses of Shingles vaccine and still experienced shingles. This case was considered as suspected vaccination failure as details regarding time to onset for shingles and laboratory confirmation regarding shingles were unknown at the time of reporting. Follow-up would not possible as no contact details were available.
Sex: U
Vaccine: VARZOS
Symptoms: Asthenia, Herpes zoster, Pain, Vaccination failure
Clinical narrative: Received Shingles vaccine had twice shingles year apart/ suspected vaccination failure; Shingles (2nd time); Shingles (1st time); Debilitating; Painful; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   The patient's past medical history included chickenpox (had when he or she was young).   On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced vaccination failure (Verbatim: Received Shingles vaccine had twice shingles year apart/ suspected vaccination failure) (serious criteria GSK medically significant), shingles (Verbatim: Shingles (2nd time)), shingles (Verbatim: Shingles (1st time)), weakness (Verbatim: Debilitating) and pain (Verbatim: Painful). The outcome of the vaccination failure was unknown and the outcome of the shingles, shingles, weakness and pain were not reported.   It was unknown if the reporter considered the vaccination failure, shingles, shingles, weakness and pain to be related to Shingles vaccine.     It was unknown if the company considered the vaccination failure, shingles, shingles, weakness and pain to be related to Shingles vaccine.   Additional Information: GSK Receipt Date: 15-MAR-2023 This case was reported by a patient via interactive digital media. The patient reported he or she was recommended to receive the shingles vaccine. The patient stated he or she received original version of Shingles vaccine and within two weeks of receiving Shingles vaccine he or she experienced shingles.. The patient stated that if you have the chance to receive shingles vaccine get it. The shingles are very debilitating and painful. The patient reported that he or she experienced Shingles two times a year apart. This case was considered as suspected vaccination failure as details regarding completion of primary schedule, time to onset for shingles and laboratory confirmation regarding shingles were unknown at the time of reporting. Follow-up would not possible as no contact details were available.; Sender's Comments:  US-GSK-US2023AMR049492:Same reporter
Sex: U
Vaccine: VARZOS
Symptoms: Guillain-Barre syndrome
Clinical narrative: Got GBS from this vaccine; This serious case was reported by a consumer via interactive digital media and described the occurrence of guillain barre syndrome in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced guillain barre syndrome (Verbatim: Got GBS from this vaccine) (serious criteria GSK medically significant). The outcome of the guillain barre syndrome was not reported.   The reporter considered the guillain barre syndrome to be related to Shingles vaccine.     The company considered the guillain barre syndrome to be related to Shingles vaccine.   Additional Information: GSK Receipt date: 02-APR-2023 This case was reported by a patient via interactive digital media The reporter reported that he/she  got(Guillain Barre syndrome) GBS from this vaccine and shingles would had been much easier.
Sex: U
Vaccine: VARZOS
Symptoms: Bell's palsy
Clinical narrative: Cousin got Bell's Palsy from it; This serious case was reported by a consumer via interactive digital media and described the occurrence of bell's palsy in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced bell's palsy (Verbatim: Cousin got Bell's Palsy from it) (serious criteria GSK medically significant). The outcome of the bell's palsy was not reported.   It was unknown if the reporter considered the bell's palsy to be related to Shingles vaccine.     It was unknown if the company considered the bell's palsy to be related to Shingles vaccine.   Additional Information: GSK Receipt Date: 01-APR-2023 This case was reported by the reporter via interactive digital media. The reporter reported that his/her cousin got Bell's Palsy after taking Shingles vaccine. This case has been linked to the case US2023AMR049593 and US2023AMR049605 reported by the same reporter.; Sender's Comments:  US-GSK-US2023AMR049593:Same reporter. US-GSK-US2023AMR049605:Same reporter.
Sex: U
Vaccine: VARZOS
Symptoms: Guillain-Barre syndrome
Clinical narrative: Some get Guilaine Barr Syndrome; This serious case was reported by a consumer via interactive digital media and described the occurrence of guillain barre syndrome in an unspecified number of patients who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced guillain barre syndrome (Verbatim: Some get Guilaine Barr Syndrome) (serious criteria GSK medically significant). The outcome of the guillain barre syndrome was not reported.   It was unknown if the reporter considered the guillain barre syndrome to be related to Shingles vaccine.     It was unknown if the company considered the guillain barre syndrome to be related to Shingles vaccine.   Additional Information: Gsk Receipt Date: 01-APR-2023 This case was reported by the reporter via interactive digital media. The reporter reported that some patients got Guillain Barre syndrome after taking Shingles vaccine. This case has been linked to the case US2023AMR049581 and US2023AMR049605 reported by the same reporter.; Sender's Comments:  US-GSK-US2023AMR049581:Same reporter. US-GSK-US2023AMR049605:Same reporter.
Sex: U
Vaccine: VARZOS
Symptoms: Herpes zoster, Vaccination failure
Clinical narrative: had the shingle shot, still had shingles/Suspected vaccination failure; Still had 2 more cases, not as bad; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   The patient's past medical history included shingles.   On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced vaccination failure (Verbatim: had the shingle shot, still had shingles/Suspected vaccination failure) (serious criteria GSK medically significant) and shingles (Verbatim: Still had 2 more cases, not as bad). The outcome of the vaccination failure was unknown and the outcome of the shingles was not reported.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.   It was unknown if the company considered the vaccination failure and shingles to be related to Shingles vaccine.   Additional Information: GSK Receipt Date: 15-MAR-2023 This case was reported by a patient via  interactive digital media. The patient had the shingles 4 times over the years, 4 different places on his/her body.  The patient had the shingle shot after the second case.  The patient still had 2 more cases of shingles that were not as bad but definitely got the shingles shot as soon as possible. The reporter stated that way back in first case was told that you only got them once, not so. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset and laboratory test confirming shingles were unknown at the time of reporting. The follow up would not possible as no contact details were available.
Sex: M
Vaccine: VARZOS, VARZOS
Symptoms: Herpes zoster, Vaccination failure
Clinical narrative: Had 2 shots an still got it/Suspected vaccination failure; Still got it; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a male patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingles vaccine and the 1st dose of Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine and Shingles vaccine, the patient experienced vaccination failure (Verbatim: Had 2 shots an still got it/Suspected vaccination failure) (serious criteria GSK medically significant) and shingles (Verbatim: Still got it). The outcome of the vaccination failure was unknown and the outcome of the shingles was not reported.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine and Shingles vaccine.    It was unknown if the company considered the vaccination failure and shingles to be related to Shingles vaccine and Shingles vaccine.   Additional Information: GSK Receipt Date: 15-MAR-2023 This case was reported by a patient's wife via interactive digital media. The patient had two shingles shots and still got shingles. This case was considered as suspected vaccination failure as details regarding time to onset and laboratory test confirming shingles were unknown at the time of reporting. The follow up would not possible as no contact details were available.
Sex: U
Vaccine: VARZOS
Symptoms: Herpes zoster, Vaccination failure
Clinical narrative: Got it and had shingles/Suspected vaccination failure; Shingles; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced vaccination failure (Verbatim: Got it and had shingles/Suspected vaccination failure) (serious criteria GSK medically significant) and shingles (Verbatim: Shingles). The outcome of the vaccination failure was unknown and the outcome of the shingles was not reported.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.   It was unknown if the company considered the vaccination failure and shingles to be related to Shingles vaccine.   Additional Information: GSK Receipt Date: 15-MAR-2023 This case was reported by a patient's friend via interactive digital media. The reporter stated that the shingles shot did not always keep you from getting shingles.  The patient got shingles vaccine and had shingles twice after it.  The reporter further stated that another pharma money maker. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset and laboratory test confirming shingles were unknown at the time of reporting. The follow up would not possible as no contact details were available.
Sex: U
Vaccine: VARZOS
Symptoms: Herpes zoster, Vaccination failure
Clinical narrative: Got shingles after shot/Suspected vaccination failure; Got shingles; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in an unspecified number of patients who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced vaccination failure (Verbatim: Got shingles after shot/Suspected vaccination failure) (serious criteria GSK medically significant) and shingles (Verbatim: Got shingles). The outcome of the vaccination failure was unknown and the outcome of the shingles was not reported.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.   It was unknown if the company considered the vaccination failure and shingles to be related to Shingles vaccine.   Additional Information: GSK Receipt Date: 15-MAR-2023 This case was reported by a consumer via interactive digital media. The reporter stated that he/she knew people that got the shingles after getting the so called shingles shot. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset and laboratory test confirming shingles were unknown at the time of reporting. The follow up would not possible as no contact details were available.
Sex: U
Vaccine: VARZOS
Symptoms: Herpes zoster, Vaccination failure
Clinical narrative: many people who got the shot and got shingles/Suspected vaccination failure; Got shingles; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in an unspecified number of patients who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced vaccination failure (Verbatim: many people who got the shot and got shingles/Suspected vaccination failure) (serious criteria GSK medically significant) and shingles (Verbatim: Got shingles). The outcome of the vaccination failure was unknown and the outcome of the shingles was not reported.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.   It was unknown if the company considered the vaccination failure and shingles to be related to Shingles vaccine.   Additional Information: GSK Receipt Date: 15-MAR-2023 This case was reported by a consumer via interactive digital media. The shingles shot did not work if you got the shingles shot, you would get shingles or very sick after the shingles shot.  The reporter knew many people who got the shot and got shingles. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset and laboratory test confirming shingles were unknown at the time of reporting. The follow up would not possible as no contact details were available.
Sex: U
Vaccine: VARZOS
Symptoms: Burning sensation, Fear, Herpes zoster, Pain, Post herpetic neuralgia
Clinical narrative: New and better drug and got them again/Suspected vaccination failure; Shingles weren't as bad; I have scared; Sharp pains; Burning; Pain from the nerve endings thrilled so bad; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   The patient's past medical history included shingles (the patient had the shingles three times). Previously administered products included Shingles vaccine (the first time he/she got the shingles shot).   On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced vaccination failure (Verbatim: New and better drug and got them again/Suspected vaccination failure) (serious criteria GSK medically significant), shingles (Verbatim: Shingles weren't as bad), fear (Verbatim: I have scared), post herpetic neuralgia (Verbatim: Pain from the nerve endings thrilled so bad), pain (Verbatim: Sharp pains) and burning sensation (Verbatim: Burning). The outcome of the vaccination failure was unknown and the outcome of the shingles, fear, pain and burning sensation were not reported and the outcome of the post herpetic neuralgia was resolved (duration 28 days).   It was unknown if the reporter considered the vaccination failure, shingles, fear, post herpetic neuralgia, pain and burning sensation to be related to Shingles vaccine.   It was unknown if the company considered the vaccination failure, shingles, fear, post herpetic neuralgia, pain and burning sensation to be related to Shingles vaccine.   Additional Information: GSK Receipt Date:16-MAR-2023 This case was reported by a patient via interactive digital media. The reporter stated he/she got shingles again and his/her doctor said that a new and better drug would make sure he/she did not get shingles again. The patient got shingles again but they were not as bad as the first two times and always on his/her left side.  The patient had scared and they took 28 days to stop with the pain from the nerve endings getting thrilled so bad.  They were so horrible.  The patient experienced burning and sharp pains.  The reporter further stated that horrible things to get. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset and laboratory test confirming shingles were unknown at the time of reporting. The follow up would not possible as no contact details were available.
Sex: U
Vaccine: VARZOS
Symptoms: Vaccination failure
Clinical narrative: New and better drug and got them again/Suspected vaccination failure; Shingles weren't as bad; I have scared; Sharp pains; Burning; Pain from the nerve endings thrilled so bad; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   The patient's past medical history included shingles (the patient had the shingles three times). Previously administered products included Shingles vaccine (the first time he/she got the shingles shot).   On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced vaccination failure (Verbatim: New and better drug and got them again/Suspected vaccination failure) (serious criteria GSK medically significant), shingles (Verbatim: Shingles weren't as bad), fear (Verbatim: I have scared), post herpetic neuralgia (Verbatim: Pain from the nerve endings thrilled so bad), pain (Verbatim: Sharp pains) and burning sensation (Verbatim: Burning). The outcome of the vaccination failure was unknown and the outcome of the shingles, fear, pain and burning sensation were not reported and the outcome of the post herpetic neuralgia was resolved (duration 28 days).   It was unknown if the reporter considered the vaccination failure, shingles, fear, post herpetic neuralgia, pain and burning sensation to be related to Shingles vaccine.   It was unknown if the company considered the vaccination failure, shingles, fear, post herpetic neuralgia, pain and burning sensation to be related to Shingles vaccine.   Additional Information: GSK Receipt Date:16-MAR-2023 This case was reported by a patient via interactive digital media. The reporter stated he/she got shingles again and his/her doctor said that a new and better drug would make sure he/she did not get shingles again. The patient got shingles again but they were not as bad as the first two times and always on his/her left side.  The patient had scared and they took 28 days to stop with the pain from the nerve endings getting thrilled so bad.  They were so horrible.  The patient experienced burning and sharp pains.  The reporter further stated that horrible things to get. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset and laboratory test confirming shingles were unknown at the time of reporting. The follow up would not possible as no contact details were available.
Sex: U
Vaccine: VARZOS
Symptoms: Herpes zoster, Vaccination failure
Clinical narrative: Know people who took the vaccine and still got shingles/Suspected vaccination failure; Shingles; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in an unspecified number of patients who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced vaccination failure (Verbatim: Know people who took the vaccine and still got shingles/Suspected vaccination failure) (serious criteria GSK medically significant) and shingles (Verbatim: Shingles). The outcome of the vaccination failure was unknown and the outcome of the shingles was not reported.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.   It was unknown if the company considered the vaccination failure and shingles to be related to Shingles vaccine.   Additional Information: GSK Receipt Date: 16-MAR-2023 This case was reported by a consumer via interactive digital media. The reporter had shingles ones, never again, that was 14 years ago and that was way too much pain. The reporter would not take the shingles vaccine. The reporter knew people who took the shingles vaccine and still got shingles. The reporter stated that did your research and asked questions. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset and laboratory test confirming shingles were unknown at the time of reporting. The follow up would not possible as no contact details were available.
Sex: U
Vaccine: VARZOS, VARZOS
Symptoms: Herpes zoster, Incomplete course of vaccination, Nerve injury, Neuropathy peripheral
Clinical narrative: Neuropathy; Shingles; Permanent nerve damage; I will NEVER take the second shingles shot; This serious case was reported by a consumer via interactive digital media and described the occurrence of neuropathy in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingles vaccine and the 2nd dose of Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine and not applicable after receiving Shingles vaccine, the patient experienced neuropathy (Verbatim: Neuropathy) (serious criteria GSK medically significant), shingles (Verbatim: Shingles), nerve damage (Verbatim: Permanent nerve damage) and incomplete course of vaccination (Verbatim: I will NEVER take the second shingles shot). The outcome of the neuropathy and nerve damage were not resolved and the outcome of the shingles was not reported and the outcome of the incomplete course of vaccination was unknown.   It was unknown if the reporter considered the neuropathy, shingles and nerve damage to be related to Shingles vaccine.     It was unknown if the company considered the neuropathy, shingles and nerve damage to be related to Shingles vaccine.   Additional Information: GSK Receipt Date: 16-MAR-2023 The case was received from the patient's sister/brother interactive digital media. The patient went to physician and stated that when he/she got them and she looked at me with a puzzled look on her face and said she was not sure what he/she had.  She gave me nothing.  The patient suffered with shingles about 8 times, with no medicine at all.  Now patient had neuropathy and had permanent nerve damage.  The patient stated that he/she took the stupid shingles shot and felt like he/she had shingles for 6 months after the shot.  The patient told physician that he/she would never take the second shingles shot. The follow-up could not be possible as no contact details were available. Till the time of reporting, the patient did not receive 2nd dose of Shingles vaccine, which led to incomplete course of vaccination.
Sex: U
Vaccine: VARZOS
Symptoms: Herpes zoster, Vaccination failure
Clinical narrative: Got new vaccine, 6 mo later shingles/Suspected vaccination failure; Full blown shingles on face; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, 6 months after receiving Shingles vaccine, the patient experienced vaccination failure (Verbatim: Got new vaccine, 6 mo later shingles/Suspected vaccination failure) (serious criteria GSK medically significant) and shingles (Verbatim: Full blown shingles on face). The outcome of the vaccination failure was unknown and the outcome of the shingles was not reported.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.     It was unknown if the company considered the vaccination failure and shingles to be related to Shingles vaccine.   Additional Information: GSK receipt date: 31-MAR-2023 The case was received from the patient's sister/brother interactive digital media. The patient got new vaccine after physician talked him/her in to it and there was 3 percent chance of getting Shingles they said. The patient stated that 6 months later they had full blown shingles on face.  Now the vaccine said, 11 percent chance of getting after vaccine and guaranteed if he/she did not got shot would never had it. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset for shingles and laboratory confirmation regarding shingles were unknown at the time of reporting. The follow-up could not be possible as no contact details were available.
Sex: F
Vaccine: VARZOS
Symptoms: Herpes zoster, Vaccination failure
Clinical narrative: wife got shot, got shingles anyway/suspected vaccination failure; shingles; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a female patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced vaccination failure (Verbatim: wife got shot, got shingles anyway/suspected vaccination failure) (serious criteria GSK medically significant) and shingles (Verbatim: shingles). The outcome of the vaccination failure was unknown and the outcome of the shingles was not reported.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.     It was unknown if the company considered the vaccination failure and shingles to be related to Shingles vaccine.   Additional Information: GSK receipt date: 31-Mar-2023 The case was received from the patient's husband via interactive digital media. The patient and her husband both got their shots but the patient got shingles anyway, sounds like covid shots. This case was considered as suspected vaccination failure since the details regarding the completion of primary vaccination schedule, time to onset and laboratory confirmation of shingles were unknown at the time of reporting. The follow-up could not be possible as no contact details were available. The case was linked with case US2023AMR050173, reported by same reporter for himself.; Sender's Comments:  US-GSK-US2023AMR050173:Same reporter.
Sex: U
Vaccine: VARZOS
Symptoms: Herpes zoster, Inappropriate schedule of product administration, Vaccination failure
Clinical narrative: Had both shots in Oct/2022, still got shingles/Suspected vaccination failure; Got shingles after immune system tanked; Had both shots in Oct/2022; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Herpes zoster (Shingrix) for prophylaxis.   The patient's past medical history included immune system disorder (immune system tanked). Concomitant products included rituximab (Rituxan Infusion).   In OCT-2022, the patient received the 2nd dose of Shingrix and the 1st dose of Shingrix. In OCT-2022, an unknown time after receiving Shingrix and not applicable after receiving Shingrix, the patient experienced drug dose administration interval too short (Verbatim: Had both shots in Oct/2022). On an unknown date, the patient experienced vaccination failure (Verbatim: Had both shots in Oct/2022, still got shingles/Suspected vaccination failure) (serious criteria GSK medically significant) and shingles (Verbatim: Got shingles after immune system tanked). The outcome of the vaccination failure and drug dose administration interval too short were unknown and the outcome of the shingles was not reported.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingrix and Shingrix.    It was unknown if the company considered the vaccination failure and shingles to be related to Shingrix and Shingrix.   Additional Information: GSK Receipt Date: 16-MAR-2023 This case was reported by a patient via interactive digital media. The patient took both Shingrix shots in October 2022.  The patient still got shingles after his/her immune system tanked due to Rituxan infusion.  The patient's PCP (primary care physician) said it would had been worse if he/she had not had the Shingrix vaccine. This case was considered as suspected vaccination failure as details regarding time to onset and laboratory test confirming shingles were unknown at the time of reporting. The patient received 2nd dose of Shingrix earlier than the recommended schedule, which led to shortening of vaccination schedule. The follow up would not possible as no contact details were available.